CD8A and neoplasm: Indeed, in patients with NSCLC, there is a statistically significant association between tumour metabolic parameters on PET and PD1/PD-L1 expression, along with the presence of CD8+ tumour infiltrating lymphocytes (TILs), in resected tumour specimens [31, 32].